A | B | C | D | E | F | G | H | CH | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9
Carpipramine
...Antipsychotic medication
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.025.182  |
| Chemical and physical data | |
| Formula | C28H38N4O |
| Molar mass | 446.639 g·mol−1 |
| 3D model (JSmol) | |
| |
Carpipramine (Prazinil, Defekton) is an atypical antipsychotic used for the treatment of schizophrenia and anxiety in France and Japan.[1][2][3][4] In addition to its neuroleptic and anxiolytic effects, carpipramine also has hypnotic properties.[3] It is structurally related to both tricyclics like imipramine and butyrophenones like haloperidol.[3]
See alsoedit
- Clocapramine
- Mosapramine
- Penfluridol (typical antipsychotic)
Referencesedit
- ^ Deniker P, Lôo H, Zarifian E, Verdeaux G, Garreau G (1977). "A new psychotropic drug: carpipramine, intermediate compound between 2 therapeutic classes". L'Encephale (in French). 3 (2): 133–148. PMID 19231.
- ^ Pislová J, Pisl I, Petránová T, Petrová M (August 1974). "Clinical experience with carpipramine (Defekton)". Activitas Nervosa Superior. 16 (3): 168–169. PMID 4608287.
- ^ a b c Párraga A, Holenz J, Buschmann H (2007). "Marketed Drugs in Development". In Vela JA, Buschmann H, Holenz J, Párraga A, Torrens A (eds.). Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application. Weinheim: Wiley-VCH. ISBN 978-3-527-31058-6.[permanent dead link]
- ^ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 978-3-88763-075-1.